Investor Presentaiton
Business Outlook - FY22 and beyond
Capex program to drive future growth
and bring in EBITDA improvement
Capex projects under commissioning
in the areas of existing and new
products; Gradual sales ramp-up of
new Capex's expected to drive
growth
• New businesses to move into plant
commissioning and sales ramp up
phase
Commencing execution of cost
improvement and value chain
integration projects
.
Business mix change to continue
Expanding product portfolio to build
globally competitive and
comprehensive range
Deeper penetration in select
International geographies
Efficiency and continuous improvement
focus
•
Building one of the most efficient
chemical complexes in India and
globally, with strong focus on EHS
and sustainability
Focus on controlling net working
capital and inventories to optimize
cash conversion cycle
Focus to improve Return on Capital Employed will continue as a key initiative
15
SUDARSHANView entire presentation